Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2014
03/26/2014CN103656683A Application of pattern recognition receptors RIG-I in preparation of antitumor drug
03/26/2014CN103656682A Anti-O-type foot-and-mouth disease polypeptide-nucleic acid double-effect virus-like particle vaccine and preparation method thereof
03/26/2014CN103656681A Small nucleic acid drug for treating acute lung injury caused by sepsis
03/26/2014CN103656680A Application of microRNA let-7e in preparation of anti-ischemic arrhythmia drugs
03/26/2014CN103656679A Preparation method of nano-particles
03/26/2014CN103656678A Application of miR-493 gene in preparation of medicament for inhibiting cancer cell proliferation
03/26/2014CN103656677A Medicine composition for treating neuron degeneration disease
03/26/2014CN103656676A Application of mi-RNA (micro-ribonucleic acid) with AAAGUGC seed sequence in preparing interleukin 8 inhibitor
03/26/2014CN103656675A DNA (Deoxyribonucleic Acid) vaccine based on CyPA (Cyclophilin A) and Gag (Glycosaminoglycan)
03/26/2014CN103656674A Use of human eIF5B gene and related drug thereof
03/26/2014CN103656673A Application of human YWHAQ gene and related drugs thereof
03/26/2014CN103656669A Compound micelle-based nano-vector, and preparation method and application thereof
03/26/2014CN103656665A Anti-tumor medical composition and preparation method thereof
03/26/2014CN103656650A pH-sensitive brain tumor two-stage targeting nano drug delivery system, and preparation method and application thereof
03/26/2014CN103656642A Method and reagent for preventing and treating colorectal cancer
03/26/2014CN103656641A Transcription mesosome Med23 subunit serving as target for preventing or treating cancer
03/26/2014CN103655476A Preparation method of CSN8shRNA nano-liposome, and application of CSN8shRNA nano-liposome
03/26/2014CN103655475A Targeted liposomes
03/26/2014CN103655452A Gene medicine delivery system and preparation method
03/26/2014CN103169986B Mosaic type DNA (Deoxyribonucleic Acid) vaccine pVAXI-Hsp 70/CD 80 for preventing and immunologically treating tuberculosis
03/26/2014CN102847171B Gene medicine for treating liver cancer and preparation method and application thereof
03/26/2014CN102746377B Epitope peptide of mycobacterium trberculosis protein antigen, and its application
03/26/2014CN102362861B Hollow composite nanoparticle with core-shell structure and preparation method thereof
03/26/2014CN102210875B LAMP-oriented BAP31 vaccine vector capable of inducing immune response and application thereof
03/26/2014CN101835902B Ultraconserved regions encoding NCRNAS
03/25/2014US8680253 Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid
03/25/2014US8680239 Use of RGM and its modulators
03/25/2014US8680069 Modified polynucleotides for the production of G-CSF
03/25/2014US8680068 Herpes virus strains
03/25/2014US8680064 ShRNA gene therapy for treatment of ischemic heart disease
03/25/2014US8680057 Tribonectins
03/25/2014US8680021 Zinc finger proteins for DNA binding and gene regulation in plants
03/25/2014US8679830 Viral vectors
03/25/2014US8679542 Cleavage kit, and gene therapy by using the same and nucleic acid cleavage detection apparatus
03/25/2014US8679477 Use of SDF-1 to mitigate scar formation
03/25/2014US8679475 Methods and compositions for tissue regeneration
03/25/2014CA2484538C Vectors with modified protease-dependent tropism
03/25/2014CA2474011C Use of the mammalian cytokine, tslp/il-50, for modulating dendritic cell activity and treatment of immune disorders
03/25/2014CA2404448C Genes involved in intestinal inflammatory diseases and use thereof
03/25/2014CA2306492C Human checkpoint kinase, hcds1, compositions and methods
03/20/2014WO2014043696A2 Compositions and methods for treating amyotrophic lateral sclerosis
03/20/2014WO2014043544A1 Multimeric oligonucleotide compounds
03/20/2014WO2014043510A1 A novel pharmaceutical composition and uses thereof
03/20/2014WO2014043484A2 Metabolic remodeling of the tumor microenvironment: migration stimulating factor (msf) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth
03/20/2014WO2014043480A1 Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
03/20/2014WO2014043397A1 Material and methods for diagnosing and treating kawasaki disease and kls
03/20/2014WO2014043311A1 Methods and compostions for the specific inhibition of myc by double-stranded rna
03/20/2014WO2014043131A1 Lentiviral vector for stem cell gene therapy of sickle cell disease
03/20/2014WO2014042920A1 Branched polyamines for delivery of biologically active materials
03/20/2014WO2014042463A1 Synthetically designed extracellular microenvironment
03/20/2014WO2014042401A1 Composition comprising cyclophilin a for preventing alopecia or improving hair restoration
03/20/2014WO2014040251A1 Isocitrate dehydrogenase 1 as diagnostic and prognostic biomarker and therapeutic target for lung cancer
03/20/2014WO2013152193A3 Methods of treating proliferative disorders with malate or derivatives thereof
03/20/2014WO2012112696A8 Therapeutic compositions and methods for antibody and fc-containing targeting molecule-based targeted delivery of bioactive molecules by bacterial minicells
03/20/2014US20140081240 Method of delivering vectors to pancreas and lungs by cannulating the aorta
03/20/2014US20140079675 Repair of Neurodegenerative Diseases
03/19/2014EP2707031A2 Protein-active agent conjugates and method for preparing the same
03/19/2014CN103649311A Oligonucleotide derivative, oligonucleotide derivative-containing pharmaceutical composition for treatment and pharmaceutical composition for diagnosis, and oligonucleotide derivative for regulation of miRNA function
03/19/2014CN103648530A Protein-active agent conjugates and method for preparing the same
03/19/2014CN103642898A Mutations in oas1 genes
03/19/2014CN103642817A cDNA (Complementary Deoxyribonucleic Acid) overall length sequence encoding extracellular ATP (Adenosine Triphosphate) acceptor P2X7 of Japanese flounder and application thereof
03/19/2014CN103642815A Recombinant lactococcus lactis for secreting and expressing Dermatophagoides pteronyssinus allergen Derp2 and application of recombinant lactococcus lactis
03/19/2014CN103642814A Recombinant lactococcus lactis for anchoring expression of dermatophagoides pteronyssinus allergen Derp2 and application thereof
03/19/2014CN103642813A Recombinant lactococcus lactis of intracellular expression dermatophagoides pteronyssinus allergen Derp2 and application thereof
03/19/2014CN103642812A Nile tilapia apoptosis factor FasL gene and applications thereof
03/19/2014CN103642808A Three siRNAs (small interfering Ribose Nucleic Acids) interfering with 2A protease gene of EV71 virus and application thereof
03/19/2014CN103642800A siRNA molecule composition, and applications thereof in treatment of hypertrophic scars
03/19/2014CN103642746A Recombinant lactococcus lactis for intracellular expression of peanut allergen and application thereof
03/19/2014CN103641911A Araneus ventricosus serine protease inhibitor AvSPI gene and encoding protein and application thereof
03/19/2014CN103641904A Engineering bacterium capable of producing human selenoprotein P mutant and application thereof
03/19/2014CN103641106A Preparation method of nano sulfonated graphene and application of nano sulfonated graphene as gene transfer material
03/19/2014CN102824634B Recombined Swinepox virus carrier vaccine capable of expressing porcine circovirus 2-type Cap protein and preparation method thereof
03/19/2014CN101524532B Single dose of a mycoplasma hyopneumoniae vaccine
03/18/2014US8673875 Method for treating atherosclerosis
03/18/2014US8673870 Combined DNA vaccine and biological modifiers for cancer therapy
03/18/2014US8673869 Determinants of sensitivity to chemotherapeutic agents
03/18/2014US8673859 GM-CSF cosmeceutical compositions and methods of use thereof
03/18/2014US8673634 Method for the treatment of hearing loss
03/18/2014US8673594 Methods for stimulating nervous system regeneration and repair by regulating arginase I and polyamine synthesis
03/18/2014US8673359 Nanoparticle compositions and methods for improved oral delivery of active agents
03/18/2014US8673319 Chimpanzee adenovirus vaccine carriers
03/18/2014US8673316 Avirulent, immunogenic flavivirus chimeras
03/18/2014US8673312 Method for one-step purification of recombinant Helicobacter pylori neutrophil-activating protein
03/18/2014US8673305 Methods of treatment with antibodies against the extracellular loops of C5aR
03/18/2014US8673289 Attenuated uracil auxotroph of an apicomplexan and use thereof
03/18/2014US8673285 Sphingoid polyalkylamine conjugates for vaccination
03/18/2014CA2553313C Cationic graft-copolymer for non-viral gene delivery vector
03/13/2014WO2014039994A2 Targeting chemotherapy agent resistance in cancer
03/13/2014WO2014039983A1 Vista modulators for diagnosis and treatment of cancer
03/13/2014WO2014039908A1 Methods and compositions for regenerating hair cells and/or supporting cells
03/13/2014WO2014039854A1 Cell systems and methods for delivering disease-specific therapies
03/13/2014WO2014039654A1 Isolation and characterization of muscle regenerating cells
03/13/2014WO2014039648A2 Compositions and methods for inhibiting hypoxia induced damage
03/13/2014WO2014039513A2 Inhibition of diacylglycerol kinase to augment adoptive t cell transfer
03/13/2014WO2014038653A1 Production method for kidney-derived somatic stem cells
03/13/2014WO2014037881A1 Compositions and methods for parkinson's disease treatment by bdnf-flag gene transfer through neurotensin polyplex to nigral dopamine neurons
03/13/2014US20140072564 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
03/12/2014CN103627785A Biomarker DACT1 for gastric cancer
03/12/2014CN103627718A S1 and N double-antigen protein recombinant plasmid capable of expressing IBV (Infectious Bronchitis Virus) and construction method and application thereof
03/12/2014CN103627714A Novel synthesized molecules of EBV (Epstein-Barr Virus) consensus DNA (Deoxyribonucleic Acid) sequence and vaccine formed thereby
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 870